| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8454857 | Lung Cancer | 2015 | 7 Pages |
Abstract
Progression patterns at the RECIST-PD during EGFR-TKI treatment of advanced NSCLC in patients harboring an EGFR mutation are widely diverse, and might be associated with clinical outcome after treatment failure.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Tatsuya Yoshida, Kiyotaka Yoh, Seiji Niho, Shigeki Umemura, Shingo Matsumoto, Hironobu Ohmatsu, Yuichiro Ohe, Koichi Goto,